Replies to post #233632 on NorthWest Biotherapeutics Inc (NWBO)

[maverick_1]

Lorie3168: So clearly MANY ENTITIES will need to compete with PFE and others in this immuno realm. NWBO will be that missing piece of the puzzle for some big guy. My best guess has been and still is BMY!!!!!

Well put, that WAS what I was thinking: but things have changed.

BUT ONE STEP AT A TIME!

At some point I will have to put it back on the top of the pedestal to really delve into.

ONCE we get across the Top line data for DC VAX L.

ONLY THEN, WILL THE REAL FUN BEGIN!

Until that happens it's ALL FANTASY LAND IMHO.

Easier first for a licensing deal..

Still maybe a question of GIA UNLESS it could optimally satisfy CEO Linda Powers and her ticking time bomb (NOT ENTIRELY HER FAULT IMHO) of fiduciary responsibilities .IF the shares vault higher and those
that need to sell get easily absorbed by the then likely growing institutional interest at that point in time: CEO Linda Powers will need to do a strategic review of what's best.

Then It's a greater need for LOTS of Big Pharma's given the two platforms NWBO offers. A lot happens in the M/A arena with Big Pharma's in terms of reconfiguring for patent expirations to former blockbusters which requires a BIG LONG TERM PLUG.

LOTS of Big Pharma CASH.

BUT NO NEED YET TO GET AHEAD of REALITY despite what may be posted due to their frustrating tenure here or their cost basis.

DIFFERENT STROKES FOR DIFFERENT FOLKS